A new review and meta-analysis, published in the journal PLOS Medicine, indicates that drug companies have increased disclosure of clinical trials of new antidepressants with negative outcomes, that is, trials that fail to show the drug is more effective than a placebo.
News
Preliminary findings show ‘count me in’ is making research more inclusive at Oxford Health
People with long COVID after hospitalisation face limited recovery after one year
Mentoring young scientists at Oxford Health BRC
Oxfordshire young people involved in childline research project
New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the University of Oxford Department of Psychiatry and Oxford Health BRC and the NSPCC, has looked at how Childline’s message boards help support young people. The research found that using the Childline message boards could reduce young people’s…
New collection of blogs from the Oxford Health BRC AIMday
In July 2021 researchers from the Oxford Health BRC hosted an Academic Industry Meeting Day (AIMday) in Experimental Medicine in Psychiatry. The day was an opportunity for researchers and industry partners to come together to share ideas and make connections as part of a series of online discussions. It was attended by nearly 90 researchers…
